Biotage

Biotage

BIOT
Uppsala, Sweden· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Biotage is an established, revenue-generating leader in life science tools, focused on separation and purification technologies critical for drug discovery and analytical testing. The company's strategy centers on providing intelligent, automated workflow solutions and a vast array of consumables to improve laboratory productivity, reliability, and yield. Through strategic acquisitions like DPX Technologies and a sustained R&D investment of 8-10% of revenue, Biotage continues to expand its technological footprint and solidify its position as a key partner to the global scientific community.

Drug DiscoveryDiagnostics

Technology Platform

Biotage's platform is built on separation science, integrating automated systems, software, and consumables for chromatography, sample preparation, and purification to create intelligent workflow solutions for life science labs.

Funding History

1
IPOUndisclosed

Opportunities

Biotage is poised to capitalize on the growing complexity of drug discovery (peptides, oligonucleotides, cell & gene therapies) and increasing global demand for environmental and food safety testing.
The integration of DPX Technologies' pipette tip technology expands its reach in high-throughput sample preparation.

Risk Factors

Key risks include dependence on cyclical pharmaceutical R&D spending, intense competition from larger conglomerates and niche players, and execution risks associated with integrating acquisitions like DPX Technologies.
Global supply chain vulnerabilities also pose an operational challenge.

Competitive Landscape

Biotage competes with large diversified players (Agilent, Waters, Thermo Fisher) and specialized firms in chromatography and sample prep. Its differentiation lies in integrated workflow solutions, deep expertise in flash purification and peptide chemistry, and a vast portfolio of high-margin consumables that drive recurring revenue.